Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Alcalay

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Antibodies (Basel, Switzerland)|November 29, 2021
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal AntibodiesTal Noy-Porat, Avishay Edri, Ron Alcalay, et al.
Nano Letters|May 25, 2021
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 InfectionUri Elia, Shahar Rotem, Erez Bar-Haim, et al.
The Journal of Infectious Diseases|August 16, 2021
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1Moria Barlev-Gross, Shay Weiss, Nir Paran, et al.
The American Journal of Tropical Medicine and Hygiene|October 22, 2024
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-SulfamethoxazoleSharon Amit, David Gur, Moshe Aftalion, et al.
Analytical and Bioanalytical Chemistry|March 26, 2021
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensMoria Barlev-Gross, Shay Weiss, Amir Ben-Shmuel, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.
Iscience|May 3, 2021
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceTal Noy-Porat, Adva Mechaly, Yinon Levy, et al.
Cell Reports|August 31, 2021
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsEfi Makdasi, Anat Zvi, Ron Alcalay, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Antibodies (Basel, Switzerland)|November 29, 2021
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal AntibodiesTal Noy-Porat, Avishay Edri, Ron Alcalay, et al.
Nano Letters|May 25, 2021
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 InfectionUri Elia, Shahar Rotem, Erez Bar-Haim, et al.
The Journal of Infectious Diseases|August 16, 2021
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1Moria Barlev-Gross, Shay Weiss, Nir Paran, et al.
The American Journal of Tropical Medicine and Hygiene|October 22, 2024
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-SulfamethoxazoleSharon Amit, David Gur, Moshe Aftalion, et al.
Analytical and Bioanalytical Chemistry|March 26, 2021
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimensMoria Barlev-Gross, Shay Weiss, Amir Ben-Shmuel, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.
Iscience|May 3, 2021
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceTal Noy-Porat, Adva Mechaly, Yinon Levy, et al.
Cell Reports|August 31, 2021
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsEfi Makdasi, Anat Zvi, Ron Alcalay, et al.
JCI Insight|May 11, 2021
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2Reut Falach, Liat Bar-On, Shlomi Lazar, et al.
Pageof 4